Novartis, which bought the rights to the NIC002, will continue to develop the anti-smoking vaccine
An assay for anti-CCP to test rheumatoid arthritis (RA) by Axis-Shield plc has been granted marketing approval in US.
BNC210, an anxiety drug compound being developed by Bionomics, has been found superior to several existing anti-anxiety, stress drugs and less addictive in clinical studies.
Side-effect free, less toxic anti-HIV drug may well be underway.
India's Wockhardt has received tentative approval from the United States Food & Drug Administration (US FDA) for a generic version of alfuzosin, a drug used in the treatment of prostate disease.